» Articles » PMID: 11102386

Sequence Variation at Two Eosinophil-associated Ribonuclease Loci in Humans

Overview
Journal Genetics
Specialty Genetics
Date 2000 Dec 5
PMID 11102386
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Host defense against invading pathogens is of great importance to the survival of higher organisms. We have been studying the evolution of mammalian eosinophil-associated ribonucleases (EARs), which are members of the ribonuclease A superfamily with known antipathogen activities. Earlier studies showed that positive selection promoted rapid diversification of paralogous EAR genes in both primates and rodents. Intraspecifically, however, it is unknown whether these genes also have divergent alleles. The recent discovery that the gene repertoire of the EAR family is much larger in rodents than in primates has led us to consider the possibility that primates maintain a large number of polymorphic alleles to compensate for a smaller gene repertoire. Here we present sequences of 2417 nucleotides at the two EAR loci, the eosinophil-derived neurotoxin (EDN, RNase 2) and eosinophil cationic protein (ECP, RNase 3), from >50 human individuals. Our data demonstrate that the nucleotide diversities (0.06-0.11%) at these loci are typical for human nuclear genes, thus permitting us to reject this polymorphism hypothesis. No significant departure from neutrality is noted and no signs of overdominant selection are observed. Similar patterns were observed in a preliminary study of chimpanzees. In summary, our results suggest that the antipathogen functions of the primate EARs are conserved after they are established and that these proteins are not currently undergoing rapid diversification in response to challenge from invading microorganisms.

Citing Articles

Evaluation of Eosinophilic Cationic Protein as a Marker of Alveolar and Cystic Echinococcosis.

Hotz J, Kaczirek K, Stremitzer S, Waneck F, Auer H, Perkmann T Pathogens. 2022; 11(2).

PMID: 35215203 PMC: 8878807. DOI: 10.3390/pathogens11020261.


Human RNase3 immune modulation by catalytic-dependent and independent modes in a macrophage-cell line infection model.

Lu L, Wei R, Prats-Ejarque G, Goetz M, Wang G, Torrent M Cell Mol Life Sci. 2020; 78(6):2963-2985.

PMID: 33226440 PMC: 8004517. DOI: 10.1007/s00018-020-03695-5.


Genetic variants of RNASE3 (ECP) and susceptibility to severe malaria in Senegalese population.

Diop G, Derbois C, Loucoubar C, Mbengue B, Ndao B, Thiam F Malar J. 2018; 17(1):61.

PMID: 29402293 PMC: 5800030. DOI: 10.1186/s12936-018-2205-9.


Eosinophil-Derived Neurotoxin (EDN/RNase 2) and the Mouse Eosinophil-Associated RNases (mEars): Expanding Roles in Promoting Host Defense.

Rosenberg H Int J Mol Sci. 2015; 16(7):15442-55.

PMID: 26184157 PMC: 4519907. DOI: 10.3390/ijms160715442.


Effect of eosinophil cationic protein on human oral squamous carcinoma cell viability.

Lima P, dos Santos F, Oliveira D, Figueiredo R, Pereira M Mol Clin Oncol. 2015; 3(2):353-356.

PMID: 25798266 PMC: 4360739. DOI: 10.3892/mco.2014.477.


References
1.
Singhania N, Dyer K, Zhang J, Deming M, Bonville C, Domachowske J . Rapid evolution of the ribonuclease A superfamily: adaptive expansion of independent gene clusters in rats and mice. J Mol Evol. 1999; 49(6):721-8. DOI: 10.1007/pl00006594. View

2.
Stahl E, Dwyer G, Mauricio R, Kreitman M, Bergelson J . Dynamics of disease resistance polymorphism at the Rpm1 locus of Arabidopsis. Nature. 1999; 400(6745):667-71. DOI: 10.1038/23260. View

3.
Zhang J, Dyer K, Rosenberg H . Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. Proc Natl Acad Sci U S A. 2000; 97(9):4701-6. PMC: 18296. DOI: 10.1073/pnas.080071397. View

4.
Hudson R, Kaplan N . Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics. 1985; 111(1):147-64. PMC: 1202594. DOI: 10.1093/genetics/111.1.147. View

5.
Waters L, Taverne J, Tai P, Spry C, Targett G, Playfair J . Killing of Plasmodium falciparum by eosinophil secretory products. Infect Immun. 1987; 55(4):877-81. PMC: 260432. DOI: 10.1128/iai.55.4.877-881.1987. View